Cerebrospinal Fluid (CSF) Management Market Size, Share & Trends | Industry Report, 2018-2026
The market is driven by the increase in investment
in research and development in the field of cerebrospinal fluid management and
increasing geriatric population worldwide.
Market Size – USD 1.45 billion in 2018, Market
Growth - CAGR of 4.7%, Market Trends –Tremendous rise in the procedures of
shunting and the increase in population of geriatric globally.
The Cerebrospinal Fluid Management market was
valued at USD 1.45 Billion in 2018 and is expected to reach USD 2.11 Billion by
2026, at a CAGR of 4.7% during the forecast period. The increase in investment
in research and development in the field of cerebrospinal fluid management and
increasing geriatric population worldwide are key factors driving the growth of
the market for managing cerebrospinal fluids.
The growth of the CSF management market is driven
by factors such as the high hydrocephalus prevalence and subsequent increase in
the number of shunting procedures and increased geriatric population.
Worldwide, there is a significant shortage of
neurophysicists and neurochirurgists. With the fast - growing aging population,
the current number of neurochirurgists is insufficient to meet the demand for
health care.
One of the biggest limitations is the inability to
produce in the required amount of time a sufficient number of trained
neurosurgeons. This lack of trained neurochirurgical professionals extends to
North America, Europe, Asia Pacific, Latin America, and Africa.
Further key findings from the report suggest
- The Cerebrospinal Fluid Management market was
valued at USD 1.45 Billion in 2018 and is expected to reach USD 2.11
Billion by 2026, at a CAGR of 4.7% during the forecast period. The
increase in investment in research and development in the field of
cerebrospinal fluid management and increasing geriatric population
worldwide are key factors driving the growth of the market for managing
cerebrospinal fluids.
- The market for hospitals is expected to grow
the largest and is estimated to reach at USD 781.5 Million in 2026, at a
CAGR of 5.4%, owing to large number of in-hospital cases related to
cerebrospinal fluid management in elderly population. The market for
Ambulatory Surgical Centers and Diagnostic Centers is expected to grow at
the highest CAGR of 6.1% during the forecast period owing to the low cost
in relation with surgery in the facility.
- The market for shunts is estimated to reach
USD 1065.1 Million in 2026, at a CAGR of 7.2%, during the forecast period.
The increasing growth in the shunts market can be attributed primarily to
the increasing number of worldwide shunting procedures and the increasing
number of revision shunt surgeries.
- The market for pediatric is expected to reach
USD 663.6 Million in 2026, at a CAGR of 5.8% during the forecast period.
This can be attributed primarily to the high prevalence of congenital
hydrocephalus in the pediatric population along with the increasing number
of shunting procedures.
- The market for Asia Pacific (APAC) is expected
to reach USD 634.7 Million in 2026, at a CAGR of 6.6%. Developing
economies like Russia, India, Brazil, China, and South Africa are among
the fastest growing hydrocephalus-based economies in the world. It is
expected that the presence of such a huge patient base in this region,
along with rising healthcare spending, will serve as an opportunity for
players in the CSF management market.
- The key players in the market are Dispomedica
(Germany), Sophysa (France), Spiegelberg GmbH (Germany), Medtronic plc
(Ireland), Integra LifeSciences (US), B. Braun (Germany), DePuy Synthes
(US), Argi Grup (Turkey), Moller Medical (Germany), Sophysa (France and
others.
Read more at: https://www.reportsanddata.com/report-detail/cerebrospinal-fluid-csf-management-market
Segments covered in the report:
This report forecasts volume and revenue growth at
a global, regional & country level, and provides an analysis on the industry
trends in each of the sub-segments from 2016 to 2026. For the purpose of this
study, Reports and Data have segmented the market on the basis of types, end
use, patient type and regional analysis.
Types (Revenue, USD Million; 2016-2026)
- Shunts
- Ventriculoperitoneal Shunts
- Ventriculoatrial Shunts
- Lumboperitoneal Shunts
- Ventriculopleural Shunts
- Fixed Valve Shunts
- Adjustable Valve Shunts
- External Drainage Systems
- External Ventricular Drainage Systems
- Lumbar Drainage Systems
End Use (Revenue, USD Million; 2016-2026)
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- Others
Patient Type (Revenue, USD Million; 2016-2026)
- Pediatric
- Adult
- Geriatric
Region (Thousand, Units and Revenue, USD Million;
2016-2026)
- North America
- US
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of the Europe
- Asia Pacific
- China
- India
- Japan
- Rest of Asia Pacific
- Latin America
- Brazil
- Rest of LATAM
- Middle East & Africa
Browse More Reports of Medical
Devices Category At: https://www.reportsanddata.com/report/category/medical-devices
Comments
Post a Comment